DSC Advisors, L.L.C., 10% Owner at KEMPHARM, INC (KMPH), bought 304,283 shares at $4.00 ($1.2M) on 2018-07-30, disclosed to the SEC on 2018-08-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.